References
- TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
- WangRSunQWangPNotch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cellsOncotarget2016755754576826735577
- SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
- MaluccioMCoveyARecent progress in understanding, diagnosing, and treating hepatocellular carcinomaCA Cancer J Clin201262639439923070690
- HaoJZhangYDengMMicroRNA control of epithelial-mesenchymal transition in cancer stem cellsInt J Cancer201413551019102724500893
- ChibaTIwamaAYokosukaOCancer stem cells in hepatocellular carcinoma: therapeutic implications based on stem cell biologyHepatol Res2016461505726123821
- Charafe-JauffretEGinestierCIovinoFBreast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signatureCancer Res20096941302131319190339
- MackillopWJCiampiATillJEBuickRNA stem cell model of human tumor growth: implications for tumor cell clonogenic assaysJ Natl Cancer Inst19837019166571928
- BonnetDDickJEHuman acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNat Med199737307379212098
- MacDonaghLGraySGBreenELung cancer stem cells: the root of resistanceCancer Lett2016372214715626797015
- TangDGPatra WalaLCalhounTProstate cancer stem/progenitor cells: identification, characterization, and implicationsMoll Carcinogen2007461114
- LathiaJDMackSCMulkearns-HubertEEValentimCLRichJNCancer stem cells in glioblastomaGenes Dev201529121203121726109046
- LeeCJDoschJSimeoneDMPancreatic cancer stem cellsJ Clin Oncol200826172806281218539958
- TongCMMaSGuanXYBiology of hepatic cancer stem cellsJ Gastroenterol Hepatol20112681229123721557770
- JiJWangXWClinical implications of cancer stem cell biology in hepatocellular carcinomaSemin Oncol201239446147222846863
- YamashitaTWangXWCancer stem cells in the development of liver cancerJ Clin Invest201312351911191823635789
- YangQWangYYangQCuprous oxide nanoparticles trigger ER stress-induced apoptosis by regulating copper trafficking and overcoming resistance to sunitinib therapy in renal cancerBiomaterials2017146728528898759
- YuBWangYYuXCuprous oxide nanoparticle-inhibited melanoma progress by targeting melanoma stem cellsInt J Nanomedicine2017122553256728435246
- DescombesPSchiblerUA liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNACell19916735695791934061
- SebastianTJohnsonPFStop and go: anti-proliferative and mitogenic functions of the transcription factor C/EBPbetaCell Cycle20065995395716687924
- RamjiDPFokaPCCAAT/enhancer-binding proteins: structure, function and regulationBiochem J2002365Pt 356157512006103
- Saint-AuretGDananJLHironMCharacterization of the transcriptional signature of C/EBPbeta isoforms (LAP/LIP) in Hep3B cells: implication of LIP in pro-survival functionsJ Hepatol20115461185119421145827
- LiWKesslerPYegerHA gene expression signature for relapse of primary wilms tumorsCancer Res20056572592260115805255
- OyaMHoriguchiAMizunoRMarumoKMuraiMIncreased activation of CCAAT/enhancer binding protein-beta correlates with the invasiveness of renal cell carcinomaClin Cancer Res2003931021102712631601
- HommaJYamanakaRYajimaNIncreased expression of CCAAT/ enhancer binding protein beta correlates with prognosis in glioma patientsOncol Rep200615359560116465418
- FangTCuiMSunJOrosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomasOncotarget2015618161061611925965830
- QiuZZouKZhuangLHepatocellular carcinoma cell lines retain the genomic and transcriptomic landscapes of primary human cancersSci Rep201662741127273737
- BuckMTurlerHChojkierMLAP (NF-IL-6), a tissue-specific transcriptional activator, is an inhibitor of hepatoma cell proliferationEMBO J19941348518607906646
- ScrepantiIRomaniLMusianiPLymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient miceEMBO J1995149193219417744000
- GuerzoniCBardiniMMarianiSAInducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cellsBlood2006107104080408916418324
- ZhuSYoonKSterneckEJohnsonPFSmartRCCCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signalingProc Natl Acad Sci U S A200299120721211756662
- ShimizuYKishimotoTOhtsukaMCCAAT/enhancer binding protein-beta promotes the survival of intravascular rat pancreatic tumor cells via antiapoptotic effectsCancer Sci200798111706171317727681
- GardinerJDAbegglenLMHuangXC/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cellsOncotarget2017816260132602628148901
- ReyaTMorrisonSJClarkeMFWeissmanILStem cells, cancer, and cancer stem cellsNature2001414685910511111689955
- ZahnowCACCAAT/enhancer binding proteins in normal mammary development and breast cancerBreast Cancer Res20024311312112052253
- GrimmSLRosenJMThe role of C/EBPbeta in mammary gland development and breast cancerJ Mammary Gland Biol Neoplasia20038219120414635794
- ZahnowCACCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinasesExpert Rev Mol Med200911e1219351437